Delivery Order SPE2DB22D1002-SPE2DB25FLHJ7
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $24,691.64 to AmerisourceBergen Drug Corp for the supply of Losartan-HCTZ 100-25 mg tablets (90-count) on August 19, 2025, with completion scheduled for August 20, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's existing Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $22,817.18 to AmerisourceBergen Drug Corp for the supply of Losartan-HCTZ 100-25 mg tablets (90-count) under a firm fixed-price contract. The award was made on August 29, 2025, with an ultimate completion date of September 2, 2025, and the product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $1,704.97 to AmerisourceBergen Drug Corp for the supply of Losartan-HCTZ 50-12.5 mg tablets (90-count) on September 10, 2025, with completion scheduled for September 11, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor's corporate office located in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Losartan-HCTZ 100-12.5 mg tablets in a quantity of 90-day supplies at a ceiling value of $18,287.44. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 15, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,491.29 to AmerisourceBergen Drug Corp for the supply of Losartan-HCTZ 50-12.5 mg tablets (90-count) on August 11, 2025, with an ultimate completion date of August 12, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and designates Conshohocken, Pennsylvania as the place of performance, which aligns with AmerisourceBergen's corporate headquarters location. The delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order valued at $18,928.44 to AmerisourceBergen Drug Corp for the supply of Losartan-HCTZ 100-12.5 mg tablets (90-count) on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Losartan-HCTZ 100-12.5 mg tablets in a 90-count quantity, with a contract ceiling value of $7,054.75. This is a firm fixed price, non-set-aside delivery order with a completion date of September 11, 2025, and performance location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $3,780.92 to AmerisourceBergen Drug Corp for the supply of Losartan-HCL 100-12.5 mg tablets (90-count) on September 9, 2025, with completion scheduled for September 10, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order valued at $1,683.45 to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Losartan-HCTZ 100-12.5 mg tablets in quantities of 90. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded procurement. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of July 29, 2025. This award represents a routine...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Losartan-HCTZ 50-12.5 mg tablets in a 90-count quantity. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $28,009.13 and is scheduled for completion by September 10, 2025. The contract represents a single line item fulfillment under AmerisourceBergen's existing pharmaceutical supply vehicle with DLA, with performance to occur...
- SPE2DB22D1002Indefinite Delivery Contract
- SPE2DB22D1002-SPE2DB25FLHJ7Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,008.72 to AmerisourceBergen Drug Corp for the supply of Losartan-HCTZ 100-25 mg tablets (90-count) on September 8, 2025, with completion scheduled for September 9, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal vendor for military and veteran healthcare systems through its comprehensive pharmaceutical supply portfolio. This delivery order for the antihypertensive medication exemplifies the company's ongoing role in supporting the DLA's medical supply chain with generic and brand-name pharmaceuticals across multiple therapeutic domains. The underlying IDC vehicle enables AmerisourceBergen to supply a vast range of pharmaceutical products, medical devices, and specialized healthcare commodities to support military healthcare programs globally, including customers such as the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 9/8/25 |